Irinotecan Hydrochloride Injection Recalled for Incorrect Formulation Calculation
West-Ward Pharmaceutical Corp. is recalling Irinotecan Hydrochloride Injection because a calculation error resulted in drug levels higher than labeled.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score under the rubric for significant potential health risks.
Plain-English summary
West-Ward Pharmaceutical Corp. is recalling specific lots of Irinotecan Hydrochloride Injection, 40 mg/2 mL (20 mg/mL), single-dose vials. The recall involves 9,020 vials distributed nationwide. The affected lots are AC0020 (Exp 03/14), AC0023, and AC0025 (Exp 08/14).
The recall was initiated after a review of the United States Pharmacopeia (USP) revealed that an incorrect calculation was used to determine the amount of irinotecan used in the formulation. This error resulted in an assay that is higher than the labeled claim. The product is a superpotent drug intended for intravenous use.
Healthcare providers and pharmacies should stop using the affected lots and contact West-Ward Pharmaceutical Corp. for further instructions. Patients who have received the medication should consult their healthcare provider if they have questions or concerns.
The recalled product
- Product
- IRINOTECAN HYDROCHLORIDE (IRINOTECAN HYDROCHLORIDE)
- Brand
- IRINOTECAN HYDROCHLORIDE
- Manufacturer
- West-Ward Pharmaceutical Corp.
- Category
- Drug — Antineoplastic
- Affected units
- 9,020
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot #: AC0020
- Exp 03/14
- AC0023
- AC0025
- Exp 08/14
UPCs (1)
- 0301439701019
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by West-Ward Pharmaceutical Corp. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · IRINOTECAN HYDROCHLORIDE
- ModerateHikma Recalls Irinotecan Hydrochloride Injection Due to Container Defect
FDA (Drugs) · 2020-06-24
- ModerateHikma Recalls Irinotecan Hydrochloride Vials Due to Container Defect
FDA (Drugs) · 2020-06-24
- SevereIngenus Recalls Irinotecan Hydrochloride Injection Due to Potency Issues
FDA (Drugs) · 2018-07-11
- SevereIngenus Recalls Irinotecan Hydrochloride Injection Due to Potency Issues
FDA (Drugs) · 2018-07-11
- SevereFDA Recalls Irinotecan Hydrochloride Injection Due to Incorrect Formulation Calculation
FDA (Drugs) · 2013-11-13
Same manufacturer · West-Ward Pharmaceutical Corp.
See all →- ModerateWest-Ward Recalls Fentanyl Citrate Injection Due to Impurity Failures
FDA (Drugs) · 2015-06-24
- ModerateWest-Ward Recalls Ethambutol Hydrochloride Tablets Due to Stability Failure
FDA (Drugs) · 2014-11-05
- ModerateWest-Ward Recalls Isoniazid Tablets Due to Dissolution Failure
FDA (Drugs) · 2014-07-09
- SevereWest-Ward Recalls Carisoprodol Tablets Due to Foreign Substance Presence
FDA (Drugs) · 2013-12-25
- ModerateWest-Ward Recalls Belladonna Alkaloids Tablets Due to Foreign Substance
FDA (Drugs) · 2013-08-21
Same hazard · dosage error
See all →- SeverePotassium Chloride Injection Strength Mislabeled on Packaging Overwrap
FDA (Drugs) · 2025-03-19
- ModerateCephalexin Oral Suspension Recalled for Incorrect Dosage Label
FDA (Drugs) · 2024-06-12
- CriticalPhenylephrine IV Bags Recalled for Double-Dose Filling System Malfunction
FDA (Drugs) · 2024-02-07
- SevereLidocaine Topical Solution Recalled for Superpotency
FDA (Drugs) · 2021-12-22
- SevereSpironolactone Tablets Recalled Due to Potential Labeling Error
FDA (Drugs) · 2021-03-24